Last Updated: November 8, 2026

Patent: 11,097,063

Summary for Patent: 11,097,063

Title:	Syringe device with a dose limiting mechanism and an additional safety mechanism
Abstract:	A syringe device for ejecting a dose of a medicament, the syringe device comprising: a dose limiting mechanism arranged to interact with a dose ejecting mechanism to prevent ejection of a dose exceeding a set dose, and a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose.
Inventor(s):	Eiland Jacob, Enggaard Christian Peter, Moeller Claus Schmidt, Markussen Tom Hede
Assignee:	Novo Nordisk A/S
Application Number:	US16250620
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 11,097,063
Patent Claims:	see list of patent claims

Details for Patent 11,097,063

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	June 16, 2005	11,097,063	2039-01-17
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	October 31, 2013	11,097,063	2039-01-17
Novo Nordisk Inc.	NOVOLOG MIX 50/50	insulin aspart protamine and insulin aspart	Injectable Suspension	021810	August 26, 2008	11,097,063	2039-01-17
Seqirus Inc.	FLUAD	influenza vaccine, adjuvanted	Injection	125510	November 24, 2015	11,097,063	2039-01-17
Seqirus Inc.	FLUAD,FLUAD QUADRIVALENT	influenza vaccine, adjuvanted	Injection	125510	February 21, 2020	11,097,063	2039-01-17
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015	11,097,063	2039-01-17
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,097,063

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Austria	E447992	⤷ Start Trial
Australia	2006278928	⤷ Start Trial
Brazil	PI0613926	⤷ Start Trial
Canada	2616248	⤷ Start Trial
China	101227942	⤷ Start Trial
Germany	602006010396	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.